These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8701415)

  • 1. Effect of lipoprotein(a) and LDL on plasminogen binding to extracellular matrix and on matrix-dependent plasminogen activation by tissue plasminogen activator.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Thromb Haemost; 1996 Mar; 75(3):497-502. PubMed ID: 8701415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysine-binding heterogeneity of Lp(a): consequences for fibrin binding and inhibition of plasminogen activation.
    Bas Leerink C; Duif PF; Gimpel JA; Kortlandt W; Bouma BN; van Rijn HJ
    Thromb Haemost; 1992 Aug; 68(2):185-8. PubMed ID: 1412165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of Apo(a) kringle IV-10 and plasminogen kringles on the interactions of lipoprotein(a) with regulatory molecules.
    Xue S; Green MA; LoGrasso PV; Boettcher BR; Madison EL; Curtiss LK; Miles LA
    Thromb Haemost; 1999 Mar; 81(3):428-35. PubMed ID: 10102473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of lipoprotein(a) by oxidation or desialylation influences its ability to compete with plasminogen for binding to the extracellular matrix.
    Pekelharing HL; Kleinveld HA; Duif PF; Bouma BN; van Rijn HJ
    Blood Coagul Fibrinolysis; 1996 Sep; 7(6):641-9. PubMed ID: 8899154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
    Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
    Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipids and progression of renal disease: role of modified low density lipoprotein and lipoprotein(a).
    Wanner C; Greiber S; Krämer-Guth A; Heinloth A; Galle J
    Kidney Int Suppl; 1997 Dec; 63():S102-6. PubMed ID: 9407434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of inhibition by lipoprotein (a) inhibition of tPA induced thrombolysis in a patient's plasma milieu.
    Lu H; Bruckert J; Soria J; Li H; de Gennes JL; Legrand A; Peynet J; Soria C
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):513-6. PubMed ID: 1966796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of Lp(a) with plasminogen binding sites on cells.
    Miles LA; Fless GM; Scanu AM; Baynham P; Sebald MT; Skocir P; Curtiss LK; Levin EG; Hoover-Plow JL; Plow EF
    Thromb Haemost; 1995 Mar; 73(3):458-65. PubMed ID: 7667829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein lipase greatly enhances the retention of lipoprotein(a) to endothelial cell-matrix.
    Auerbach BJ; Cain W; Ansong M; Newton RS; Saxena U; Bisgaier CL
    Atherosclerosis; 1999 Jan; 142(1):89-96. PubMed ID: 9920509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) binds to low-density lipoprotein at two distant sites in lipoprotein(a).
    Xu S
    Biochemistry; 1998 Jun; 37(26):9284-94. PubMed ID: 9649309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potential basis for the thrombotic risks associated with lipoprotein(a).
    Miles LA; Fless GM; Levin EG; Scanu AM; Plow EF
    Nature; 1989 May; 339(6222):301-3. PubMed ID: 2542796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
    Gabel BR; Koschinsky ML
    Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of the structural elements in plasminogen required for high-affinity binding to apolipoprotein(a): a study utilizing surface plasmon resonance.
    Hancock MA; Spencer CA; Koschinsky ML
    Biochemistry; 2004 Sep; 43(38):12237-48. PubMed ID: 15379562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetyl-LDL stimulates macrophage-dependent plasminogen activation and degradation of extracellular matrix.
    Falcone DJ; Ferenc MJ
    J Cell Physiol; 1988 Jun; 135(3):387-96. PubMed ID: 3397384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidized LDL binding to a macrophage-secreted extracellular matrix.
    Kaplan M; Aviram M
    Biochem Biophys Res Commun; 1997 Aug; 237(2):271-6. PubMed ID: 9268699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a): a genetically determined lipoprotein containing a glycoprotein of the plasminogen family.
    Scanu AM
    Semin Thromb Hemost; 1988 Jul; 14(3):266-70. PubMed ID: 2972066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation decreases low density lipoprotein association with the subendothelium extracellular matrix.
    Savion N; Zavaro O; Kotev-Emeth S
    Biochem Biophys Res Commun; 1998 Apr; 245(2):497-501. PubMed ID: 9571183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fibrinolysis by lipoprotein(a).
    Anglés-Cano E; de la Peña Díaz A; Loyau S
    Ann N Y Acad Sci; 2001; 936():261-75. PubMed ID: 11460483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-type plasminogen activator binds to and is inhibited by surface-bound lipoprotein(a) and low-density lipoprotein.
    Simon DI; Fless GM; Scanu AM; Loscalzo J
    Biochemistry; 1991 Jul; 30(27):6671-7. PubMed ID: 1829635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.